<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A patient whose initial hematologic evaluation suggested the diagnosis of a <z:hpo ids='HP_0001937'>microangiopathic hemolytic anemia</z:hpo> (MAHA) was further evaluated and found to have <z:e sem="disease" ids="C0023440" disease_type="Neoplastic Process" abbrv="">erythroleukemia</z:e> (<z:e sem="disease" ids="C0023440" disease_type="Neoplastic Process" abbrv="">DiGuglielmo's syndrome</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>This prompted us to review retrospectively the peripheral blood <z:mp ids='MP_0000002'>morphology</z:mp> of 12 patients with <z:e sem="disease" ids="C0023440" disease_type="Neoplastic Process" abbrv="">erythroleukemia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0011273'>Anisocytosis</z:hpo>, <z:hpo ids='HP_0004447'>poikilocytosis</z:hpo>, <z:mp ids='MP_0000248'>macrocytosis</z:mp>, and nucleated red cells have been described in patients with <z:e sem="disease" ids="C0023440" disease_type="Neoplastic Process" abbrv="">erythroleukemia</z:e>; however, changes characteristic of a microangiopathic hemolytic process (<z:hpo ids='HP_0001981'>schistocytes</z:hpo>) have not been previously described </plain></SENT>
<SENT sid="3" pm="."><plain>Our patients with <z:e sem="disease" ids="C0023440" disease_type="Neoplastic Process" abbrv="">erythroleukemia</z:e> had prominent helmet and fragmented red cells, as well as <z:hpo ids='HP_0004445'>elliptocytosis</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Six of our 12 patients with <z:e sem="disease" ids="C0023440" disease_type="Neoplastic Process" abbrv="">erythroleukemia</z:e> did not have blasts on their peripheral smear, and platelets were decreased (platelet count ranged from 2 to 92 X 10(3)/microliter), resulting in changes similar to patients with MAHA due to thrombotic thrombocytopenic <z:hpo ids='HP_0000979'>purpura</z:hpo> (<z:chebi fb="1" ids="18284">TTP</z:chebi>), traumatic RBC lysis, and <z:hpo ids='HP_0005521'>disseminated intravascular coagulation</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Our data indicate the RBC changes characteristic of MAHA are commonly seen in <z:e sem="disease" ids="C0023440" disease_type="Neoplastic Process" abbrv="">erythroleukemia</z:e>, and that as many as half of these patients may not have white cell changes suggestive of <z:hpo ids='HP_0001909'>leukemia</z:hpo> on the peripheral smear </plain></SENT>
<SENT sid="6" pm="."><plain>Patients presenting with <z:hpo ids='HP_0001937'>microangiopathic hemolytic anemia</z:hpo> require a bone marrow examination to confirm or exclude a <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> </plain></SENT>
</text></document>